• Nem Talált Eredményt

IV. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science

N/A
N/A
Protected

Academic year: 2022

Ossza meg "IV. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science"

Copied!
1
0
0

Teljes szövegt

(1)

IV. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science

January 19-21, 2022 - Szeged, Hungary

51 DOI: 10.14232/syrptbrs.2022.51

Improvement of dimenhydrinate solubility by complexation with β-cyclodextrin

Lamija Hindija, Jasmina Hadžiabdić, Edina Vranić, Ognjenka Rahić

University of Sarajevo, Faculty of Pharmacy, Department of Pharmaceutical Technology, Sarajevo, Bosnia and Herzegovina

Dimenhydrinate (DMH) is slightly soluble drug which belongs to class II of Biopharmaceutics classification system (low solubility, high permeability). To improve DMH solubility and enhance its bioavailability inclusion complexes with cyclodextrins (CDs) can be formed. These cyclic oligosaccharides with a hydrophilic outer surface incorporate a drug in the lipophilic central cavity and increase its solubility.

Phase solubility studies, where the change of drug solubility is corresponding to CD concentration, can be conducted to assess the binding characteristics of DMH and β- cyclodextrin (β-CD) and to determine the values of stability constant (Ks), complexation efficacy (CE) and utility number (UCD). A-type phase solubility isotherms are characteristic for water soluble complexes. Optimal value of KS is 100-5000 M-1. Lower values imply very labile complexes with premature drug release and insignificant solubility improvement. Higher values imply very stable complexes with incomplete or obstructed drug release from CD cavity. The value of CE depends only on the slope of phase-solubility profile and it’s is less variable compared to KS value which depends on the intercept and intrinsic solubility which are affected by excipients used in formulation.

The results of the conducted phase solubility studies showed AL-type isotherm. The slope was less than unity which implies that β-CD enhances the solubility of DMH linearly and forms 1:1 complex. The value of Ks was 171,10 M-1 and the CE value was 3,45. UCD value ≥ 1 was achieved in 1,8% solution of β-CD thus solubilization of 25 mg of DMH was adequately provided by complexation with β-CD.

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

Furthermore, analytical measurements and assessments were carried out using the different values for the alginate concentration, mixing time and pH which served as

3 Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.. 4 University of Chemistry

1 University of Szeged, Faculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, Szeged, Hungary.. 2 University of Szeged, Faculty of Pharmacy,

The zeta potential and vesicle size values were investigated, and furthermore, the possible correlation between various EOs with different concentrations was identified in

1 Medical University of Plovdiv, Faculty of Pharmacy, Department of Pharmaceutical Sciences, Plovdiv, Bulgaria.. 2 Medical University of Plovdiv, Faculty of Pharmacy,

SNEEDS have been widely investigated in recent years to improve the oral bioavailability of poorly water-soluble drugs, but it was also reported that these systems can address

In summary, the conducted study has revealed promising results which showed the possible pathways for further application of green extraction techniques in

My PhD work aims to formulate in situ gel-forming mucoadhesive eye drops containing dexamethasone-cyclodextrin inclusion complex to improve the residence time and solubility of